Iqvia Holdings Stock News

IQVIA (NYSE:IQV) had its target price upped by stock analysts at UBS Group from $298.00 to $310.00 in a research report issued to clients and investors on Wednesday, The Fly reports. The brokerage currently has a buy rating on the medical research companys stock. UBS Groups price objective would suggest a potential upside of 16.28% []

IQVIA (NYSE:IQV) had its target price hoisted by research analysts at Jefferies Financial Group from $300.00 to $309.00 in a note issued to investors on Wednesday, Price Targets.com reports. The firm currently has a buy rating on the medical research companys stock. Jefferies Financial Groups price target would indicate a potential upside of 15.90% from []

Tower Bridge Advisors raised its stake in IQVIA Holdings Inc. (NYSE:IQV) by 0.1% in the third quarter, HoldingsChannel reports. The fund owned 127,767 shares of the medical research companys stock after purchasing an additional 86 shares during the period. IQVIA accounts for approximately 2.0% of Tower Bridge Advisors investment portfolio, making the stock its 7th []

IQVIA (NYSE:IQV) had its price objective raised by Citigroup from $300.00 to $320.00 in a research note published on Wednesday morning, The Fly reports. The firm currently has a buy rating on the medical research companys stock. Other research analysts have also issued reports about the stock. KeyCorp upped their price objective on shares of []

IQVIA Holdings Inc. (NYSE:IQV) hit a new 52-week high during mid-day trading on Tuesday . The stock traded as high as $265.68 and last traded at $265.68, with a volume of 40945 shares. The stock had previously closed at $251.81. Several equities analysts have recently issued reports on IQV shares. KeyCorp boosted their price objective []

IQVIA Holdings found using ticker (IQV) have now 18 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The range between the high target price and low target price is between 320 and 250 with a mean TP of 291.5. Given that the stocks previous close was at 267.54 this now indicates there is a potential upside of 9.0%. The day 50 moving average is 249.85 and the 200 day MA is 247.54. The company has a market cap of $50,521m. Company Website: /> [stock_market_widget type="chart" symbol="IQV" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients'' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services.

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Vanguard Mid-Cap ETF (Symbol: VO) where we have detected an approximate $635.0 million dollar inflow thats a 1.1% increase week over week in outstanding units (from 216,293,020 to 218,743,061). Among the largest underlying components [] The post Notable ETF Inflow Detected VO, MRVL, MSCI, IQV appeared first on UK Stocks, Forex, Commodities, Crypto, Live Market News- Daily Forex News .

Evercore ISI restated their outperform rating on shares of IQVIA (NYSE:IQV) in a report published on Friday, The Fly reports. IQV has been the subject of several other research reports. Zacks Investment Research downgraded shares of IQVIA from a buy rating to a hold rating and set a $269.00 target price for the company. in []

Shares of IQVIA Holdings Inc. (NYSE:IQV) have been given a consensus rating of Buy by the twenty ratings firms that are covering the firm, Marketbeat reports. Two analysts have rated the stock with a hold recommendation and sixteen have assigned a buy recommendation to the company. The average 1-year target price among brokerages that have []

Related Stocks: IQV , NYT , FAST , BKNG , MKTX , VRTX , GSHD , MORN , ETSY , KNSL , SPGI , CAE , BF.B ,

Related Stocks: IQV , UBER , BKNG , SMAR , ATUS , V , GDS ,

IQVIA's (IQV) combined offerings of research and development, and commercial services help it build a strong client base.

IQVIA Holdings, Inc. (IQV) CEO Ari Bousbib on Q3 2021 Results - Earnings Call Transcript

IQVIA Holdings Inc (NYSE: IQV) has posted Q3 adjusted EPS of $2.17, up 33% Y/Y, marginally surpassing the consensus of $2.12 Revenue of $3.4 billion increased 21.7% on a reported basis and 21.1 perc

IQVIA (IQV) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.